Colocalization of USP1 and RN domain of Bcr¬Abl oncoprotein in terms of cronic myeloid leukemia cell rearrangements
Saved in:
| Date: | 2016 |
|---|---|
| Main Authors: | S. V. Antonenko, D. S. Gurianov, G. D. Telegeev |
| Format: | Article |
| Language: | English |
| Published: |
2016
|
| Series: | Cytology and genetics |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000852809 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Bcr-Abl oncoprotein interacts with GLG1 in K562 cells: role in pathogenesis of chronic myeloid leukemia
by: S. V. Antonenko, et al.
Published: (2020)
by: S. V. Antonenko, et al.
Published: (2020)
Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells
by: Antonenko, S.V., et al.
Published: (2023)
by: Antonenko, S.V., et al.
Published: (2023)
Ubiquitin specific proteases 1 (USP1) – potential partner of Bcr-Abl oncoprotein: bioiformatic analysis and recombinant constructs creation
by: S. V. Antonenko, et al.
Published: (2014)
by: S. V. Antonenko, et al.
Published: (2014)
Analysis of cellular localization of RN domain of Bcr-Abl with USP1 protein and development of software for estimation of their phosphorylation sites
by: S. V. Antonenko, et al.
Published: (2018)
by: S. V. Antonenko, et al.
Published: (2018)
Role of the hybrid Bcr/Abl kinase in the pathogenesis of chronic myeloid leukemia lacking C-Abl and CXCR4 proteins
by: L. A. Polishchuk, et al.
Published: (2014)
by: L. A. Polishchuk, et al.
Published: (2014)
Role of the hybrid Bcr/Abl kinase in the pathogenesis of chronic myeloid leukemia lacking C-Abl and CXCR4 proteins
by: Polishchuk, L.A., et al.
Published: (2014)
by: Polishchuk, L.A., et al.
Published: (2014)
Frequency and spectrum of atypical BCR-ABL1 transcripts in chronic myeloid leukemia
by: Kearney, L., et al.
Published: (2023)
by: Kearney, L., et al.
Published: (2023)
Colocalization of cortactin and PH domain of BCR in HEK293T cells and its potential role in cell signaling.
by: D. S. Gurianov, et al.
Published: (2016)
by: D. S. Gurianov, et al.
Published: (2016)
Colocalization of cortactin and PH domain of BCR in HEK293T cells and its potential role in cell signaling
by: Gurianov, D.S., et al.
Published: (2016)
by: Gurianov, D.S., et al.
Published: (2016)
Phosphorylation of Tyr sites of USP1 protein in K562 cell as a progression factor of chronic myeloid leukemia
by: S. V. Antonenko, et al.
Published: (2019)
by: S. V. Antonenko, et al.
Published: (2019)
Immunocytochemical study of BCR and bcr-abl localization in K562 cells
by: Telegeev, G.D., et al.
Published: (2010)
by: Telegeev, G.D., et al.
Published: (2010)
Colocalization of BCR protein with clathrin, actin, and cortactin suggests its possible role in the regulation of actin branching and clathrin-mediated endocytosis
by: D. S. Hurianov, et al.
Published: (2021)
by: D. S. Hurianov, et al.
Published: (2021)
The TGF-beta — SMAD pathway is inactivated in cronic lymphocytic leukemia cells
by: Matveeva, A., et al.
Published: (2017)
by: Matveeva, A., et al.
Published: (2017)
Proteins-partners of PH domain of BCR-ABL protein: creation of DNA constructs to uncover molecular characteristics of CML development
by: S. V. Antonenko, et al.
Published: (2017)
by: S. V. Antonenko, et al.
Published: (2017)
ЯДЕРНА ЛОКАЛІЗАЦІЯ BCR І КОРТАКТИНУ ВКАЗУЄ НА ЇХ ПОТЕНЦІЙНУ РОЛЬ В РЕГУЛЯЦІЇ РОЗГАЛУЖЕННЯ АКТИНУ В ЯДРІ
by: Gurianov, D.S., et al.
Published: (2023)
by: Gurianov, D.S., et al.
Published: (2023)
Stem cells in acute myeloid leukemias
by: D. F. Gluzman, et al.
Published: (2018)
by: D. F. Gluzman, et al.
Published: (2018)
Вивчення впливу DH/PH доменів білка Bcr на субклітинну локалізацію онкопротеїну Bcr-Abl
by: Телегєєв, Г.Д., et al.
Published: (2010)
by: Телегєєв, Г.Д., et al.
Published: (2010)
Chronic myeloid leukemia in patient with the klinefelter syndrome
by: Andreieva, S.V., et al.
Published: (2016)
by: Andreieva, S.V., et al.
Published: (2016)
Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia
by: Langabeer, S.E., et al.
Published: (2023)
by: Langabeer, S.E., et al.
Published: (2023)
Вивчення bcr частини гібридного гена bcr-abl як шлях до розуміння патогенезу лейкемій при транслокації (9:22)
by: Телегєєв, Г.Д., et al.
Published: (2009)
by: Телегєєв, Г.Д., et al.
Published: (2009)
Aberrant expression of placental-like alkaline phosphatase in chronic myeloid leukemia cells in vitro and its modulation by vitamin E
by: Shvachko, L.P., et al.
Published: (2023)
by: Shvachko, L.P., et al.
Published: (2023)
Features of the molecular expression of alkaline phosphatase gene in chronic myeloid leukemia
by: L. P. Shvachko, et al.
Published: (2017)
by: L. P. Shvachko, et al.
Published: (2017)
The activity of erythropoietin as the pathogenetic component of anemia in acute myeloid leukemia
by: I. I. Lanovenko, et al.
Published: (2014)
by: I. I. Lanovenko, et al.
Published: (2014)
EMT-mechanizm induces the leukemic stemness phenotype in myeloid leukemias
by: L. P. Shvachko
Published: (2018)
by: L. P. Shvachko
Published: (2018)
Prognostic significance of monosomal karyotype in adult acute myeloid leukemia
by: O. Zotova, et al.
Published: (2019)
by: O. Zotova, et al.
Published: (2019)
Мутації bcr/abl гібридного гена як фактор пухлинної прогресії при хронічній мієлоїдній лейкемії
by: Телегеэв, Г.Д., et al.
Published: (2000)
by: Телегеэв, Г.Д., et al.
Published: (2000)
Chronic lymphocytic leukemia and acute myeloid leukemias in structure of hematological malignancies in Ukrainian population in post-Chernobyl period
by: D. F. Gluzman, et al.
Published: (2017)
by: D. F. Gluzman, et al.
Published: (2017)
Assessment of trace elements in serum of acute lymphoblastic and myeloid leukemia patients
by: Valadbeigi, S., et al.
Published: (2023)
by: Valadbeigi, S., et al.
Published: (2023)
Heart electrical instability in patients with acute myeloid leukemia with anemic syndrome
by: I. I. Lanovenko, et al.
Published: (2016)
by: I. I. Lanovenko, et al.
Published: (2016)
Identification of leukemic stem cells for targeted therapy of patients with acute myeloid leukemia
by: D. F. Gluzman, et al.
Published: (2019)
by: D. F. Gluzman, et al.
Published: (2019)
Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia
by: Ivanivska, T.S., et al.
Published: (2023)
by: Ivanivska, T.S., et al.
Published: (2023)
Визначення транслокації BCR/ABL при радіаційно-асоційованих гострих мієлоїдних лейкеміях методом флуоресцентної in situ гібридизації
by: Клименко, С.В., et al.
Published: (2005)
by: Клименко, С.В., et al.
Published: (2005)
Делеція п'ятого екзона гена bcr/abl при гострому лімфобластному лейкозі з філадельфійською хромосомою
by: Телегеєв, Г.Д., et al.
Published: (2001)
by: Телегеєв, Г.Д., et al.
Published: (2001)
S-colocalization and Adams cocompletion
by: S. B. Choudhury, et al.
Published: (2023)
by: S. B. Choudhury, et al.
Published: (2023)
$S$-colocalization and Adams cocompletion
by: Choudhury, Snigdha Bharati, et al.
Published: (2023)
by: Choudhury, Snigdha Bharati, et al.
Published: (2023)
Generic imatinib in the treatment of chronic myeloid leukemia: two years’ experience in latvia
by: Lejniece, S., et al.
Published: (2017)
by: Lejniece, S., et al.
Published: (2017)
Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia
by: Horacek, J.M., et al.
Published: (2008)
by: Horacek, J.M., et al.
Published: (2008)
Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine
by: Gunduz, U., et al.
Published: (2006)
by: Gunduz, U., et al.
Published: (2006)
The determination of the relapse risk of chronic myeloid leukemia using the indicators of the functional activity of bone marrow and sokal index
by: D. I. Bilko, et al.
Published: (2014)
by: D. I. Bilko, et al.
Published: (2014)
Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
by: I. O. Sviezhentseva, et al.
Published: (2015)
by: I. O. Sviezhentseva, et al.
Published: (2015)
Similar Items
-
Bcr-Abl oncoprotein interacts with GLG1 in K562 cells: role in pathogenesis of chronic myeloid leukemia
by: S. V. Antonenko, et al.
Published: (2020) -
Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells
by: Antonenko, S.V., et al.
Published: (2023) -
Ubiquitin specific proteases 1 (USP1) – potential partner of Bcr-Abl oncoprotein: bioiformatic analysis and recombinant constructs creation
by: S. V. Antonenko, et al.
Published: (2014) -
Analysis of cellular localization of RN domain of Bcr-Abl with USP1 protein and development of software for estimation of their phosphorylation sites
by: S. V. Antonenko, et al.
Published: (2018) -
Role of the hybrid Bcr/Abl kinase in the pathogenesis of chronic myeloid leukemia lacking C-Abl and CXCR4 proteins
by: L. A. Polishchuk, et al.
Published: (2014)